Strategic partnership Bionova Scientific has a recent licensing partnership with Scarab Genomics and is under the Asahi Kasei umbrella, signaling strong collaboration appeal to biologics clients and a path to co-develop or co-manufacture advanced platforms.

Expanded capacity The company expanded facilities in Texas to support plasmid DNA development and production, indicating capacity growth and capability expansion that can attract clients needing scalable pDNA and early-stage development services.

Full service CDMO As a full-service biologics CDMO with end-to-end capabilities from material generation to GMP manufacturing, Bionova offers a single sourcing option for biotech firms seeking streamlined development timelines and reduced vendor management.

Technology leverage Sizable tech stack and enterprise tools (SAP, PostgreSQL, SharePoint, WordPress, Microsoft 365) suggest solid operations, data integrity, and digital collaboration strengths that can be highlighted to prospective clients prioritizing quality systems and regulatory compliance.

Financial signals Revenue range of 50–100 million USD and notable facility expansions imply a financially stable, growing player capable of investing in new projects, potentially open to long-term CDMO partnerships and milestone-based programs.